
Medtronic PLC MDT
Quarterly report 2025-Q4
added 02-24-2026
Country |
|
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
Shares |
1.29 B |
Market Cap[1] |
$ 101 B |
EBITDA (LTM) |
$ 7.85 B |
P/E (LTM) |
20.58 |
P/S (LTM) |
2.87 |
EPS (LTM) |
3.78 |
Medtronic is an international medical company that specializes in developing and manufacturing innovative medical technologies. The company was founded in the United States in 1949 and today is a leader in the field of medical technology.
Medtronic offers a wide range of products and services in cardiology, endocrinology, neurology, orthopedics, surgery, and more. Among the company's products are implantable cardiac pacemakers, glucose meters, insulin infusion pumps, pain management systems, deep brain stimulation devices, and much more.
Medtronic is actively engaged in scientific research and development in the field of medicine. As a result, its products are the most effective and safe for patients. The company also provides training and consultations to doctors and medical personnel on the use of its products.
Medtronic has offices and representatives in more than 160 countries around the world, which allows it to provide maximum accessibility of its products and services to patients worldwide. Medtronic is a reliable partner for medical institutions and patients who need innovative solutions to maintain health and life.
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
IRIDEX Corporation
IRIX
|
$ 1.01 | - | $ 17.1 M | Nasdaq Global Select Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
ClearPoint Neuro
CLPT
|
$ 11.44 | -2.22 % | $ 324 M | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Alphatec Holdings
ATEC
|
$ 8.27 | 0.49 % | $ 1.24 B | Nasdaq Global Select Market | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
EDAP TMS S.A.
EDAP
|
$ 4.3 | -2.27 % | $ 161 M | Nasdaq Global Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
LivaNova PLC
LIVN
|
$ 73.83 | 0.26 % | $ 4.03 B | Nasdaq Global Select Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
LENSAR
LNSR
|
$ 6.09 | 2.35 % | $ 72.8 M | Nasdaq Capital Market | ||
|
Helius Medical Technologies
HSDT
|
$ 2.29 | -2.97 % | $ 50.5 M | Nasdaq Capital Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.46 | 0.17 % | $ 28.6 M | Nasdaq Capital Market | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 18.37 | -0.33 % | $ 431 M | Nasdaq Global Select Market,SPB | ||
|
Delcath Systems
DCTH
|
$ 11.02 | -3.76 % | $ 395 M | Nasdaq Capital Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
MiMedx Group
MDXG
|
$ 3.62 | 0.28 % | $ 535 M | Nasdaq Global Select Market | ||
|
Pulmonx Corporation
LUNG
|
$ 1.55 | 0.65 % | $ 63.1 M | Nasdaq Global Select Market | ||
|
Electromed
ELMD
|
$ 38.22 | -0.93 % | $ 323 M | NYSE American | ||
|
Myomo
MYO
|
$ 1.04 | 9.5 % | $ 43.5 M | NYSE American | ||
|
Butterfly Network
BFLY
|
$ 4.47 | -0.11 % | $ 1.1 B | NYSE | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
Sintx Technologies
SINT
|
$ 2.39 | 3.91 % | $ 6.63 M | Nasdaq Capital Market | ||
|
Orthofix Medical
OFIX
|
$ 10.75 | 3.27 % | $ 426 M | Nasdaq Global Select Market,SPB | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
Profound Medical Corp.
PROF
|
$ 6.83 | -2.01 % | $ 206 M | Nasdaq Global Select Market | ||
|
Globus Medical
GMED
|
$ 84.81 | 0.24 % | $ 11.5 B | NYSE,SPB | ||
|
Insulet Corporation
PODD
|
$ 154.87 | -1.29 % | $ 10.9 B | Nasdaq Global Select Market,SPB | ||
|
CONMED Corporation
CNMD
|
$ 37.23 | 0.57 % | $ 1.16 B | NYSE,SPB | ||
|
Inspire Medical Systems
INSP
|
$ 43.84 | -2.01 % | $ 1.29 B | NYSE,SPB | ||
|
Integer Holdings Corporation
ITGR
|
$ 89.28 | -0.8 % | $ 3.1 B | NYSE,SPB | ||
|
TransMedics Group
TMDX
|
$ 68.94 | 0.12 % | $ 2.34 B | Nasdaq Global Market | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Edwards Lifesciences Corporation
EW
|
$ 85.78 | 3.1 % | $ 50.2 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.